Skip to main content

Table 2 Laboratory parameters and disease severity indices in patients with cirrhosis (n = 35)

From: Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration

Parameter Value
Hemoglobin (g/dL) (reference: >13.0) 11.0 (6.6–14.7)
Leucocyte count (×1000/μL) (reference: 4.0–7.0) 4.5 (1.9–9.2)
Platelet count (×1000/μL) (reference: 150–400) 75.0 (22–184)
Serum bilirubin (mg/dL) (reference: <1.2) 2.0 (0.5–8.0)
Serum aspartate transaminase (IU/L) (reference: <40) 68.0 (26–273)
Serum alanine transaminase (IU/L) (reference: <40) 40.0 (17–162)
Serum alkaline phosphatase (IU/L) (reference: <150) 141.0 (36–455)
Serum albumin (g/dL) (reference: 3.5–5.0) 3.4 (2.1–4.5)
Serum creatinine (mg/dL) (reference: <1.2) 0.9 (0.6–1.8)
Prothrombin time (International normalized ratio) 1.3 (0.9–2.8)
Child-Turcotte-Pugh score 7.0 (5–11)
Model for end-stage liver disease (MELD) score 13.0 (6–25)
Cause of liver disease
 Hepatitis C 9  
 Hepatitis B 7  
 Alcohol 7  
 Autoimmune 1  
 Cryptogenic 11  
Child-Pugh class
 A 10 (29%)
 B 21 (60%)
 C 4 (11%)
Clinical history
 Ascites 19 (54%)
 Spontaneous bacterial peritonitis 6 (32%)
 Hepatic encephalopathy 4 (11%)
 Variceal bleed 8 (23%)
  1. Data are shown as median (range) or as number (%)